home / stock / apha / apha news


APHA News and Press, Aphria Inc. From 04/28/21

Stock Information

Company Name: Aphria Inc.
Stock Symbol: APHA
Market: NYSE
Website: tilray.com

Menu

APHA APHA Quote APHA Short APHA News APHA Articles APHA Message Board
Get APHA Alerts

News, Short Squeeze, Breakout and More Instantly...

APHA - What the Tilray-Aphria Deal Means for Cannabis Investors

Boy, has 2021 been an interesting year for deal making. We’ve seen a tonne of deals proposed and a number of high-profile deals set to close. Among these, there’s a big merger in the cannabis sector investors have their eye on right now. Let’s dive into the details ...

APHA - Why Aurora Cannabis, Hexo, and Aphria Stocks Are On Fire Today

Marijuana stocks are lighting up in Wednesday afternoon trading, with shares of Aurora Cannabis (NYSE: ACB) and Aphria (NASDAQ: APHA) both gaining 4.8% through 1 p.m. EDT, and Hexo (NYSE: HEXO) surging more than twice as much, up 11%. You can thank Bank of Am...

APHA - 7 Marijuana Stocks to Buy As Canada's Consumption Continues to Rise

InvestorPlace - Stock Market News, Stock Advice & Trading Tips When it comes to cannabis stocks, what can get lost in the “weeds,” so to speak, is the gains that these names have provided on a year-to-date (YTD) basis. Yes, the sector has roughly halved from its February ...

APHA - Tilray, Canopy are buys due to potential U.S. legalization, CBD beverages - BoA

Tilray (TLRY) and Canopy Growth (CGC) are both buys, according to Bank of America, because of their ability to enter the U.S. market should federal marijuana legalization occur and CBD beverage distribution.BoA analyst Heather Balsky has reinstated coverage of Tilray and Canopy with price tar...

APHA - Top Canadian Marijuana Stocks For Your Portfolio In 2021

Cannabis Stocks In 2021 And Market Performance Earlier in the year, we got a chance to see what a rally in the cannabis sector might look like. After climbing in January and reaching new highs in February top marijuana stocks began to see declines in market value. Although this down...

APHA - Cronos: The Most Confusing Cannabis Stock

We continue to be perplexed by the elevated valuation of Cronos; its 32x EV/Sales is difficult to be justified based on fundamentals. It reported $47M revenue and $147M negative EBITDA for 2020 which we view as the weakest among the top 10 Canadian LPs. We see no appeal in Cronos ...

APHA - These 4 Canadian Stocks Are Down Over 40%: Should You Buy?

Despite the rising COVID-19 cases worldwide, Canadian equity markets have remained strong, with the S&P/TSX Composite Index trading close to its all-time high. The expectations of demand recovery and improvement in corporate earnings have driven the equity markets higher. However, t...

APHA - Humana price target unchanged at Cantor despite Kindred deal; eyes on cannabis names as BofA resumes coverage; and more in today's analyst action

Cannabis stocks are in focus after Bank of America resumed coverage on several Canadian names in the sector including Canopy Growth, Tilray, and Cronos Group. But first on Cantor’s take on Humana - Kindred deal.Humana deal points to provider/payer convergence: CantorYesterday, after th...

APHA - HEXO: The Winning Streak In Canada Continues

HEXO announced strong results for Q2 F2021 that showed continued revenue growth and improvement in profitability. While HEXO has announced consecutive quarters of improvements, it has outperformed most of the other Canadian LPs, some of which struggled and lost market share. Despi...

APHA - Tilray Stock Has Valuation Problems That a Merger Just Won't Solve

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tilray (NASDAQ: TLRY ) stock has been one of the big players in the marijuana industry, but this planned merger with Aphria (NASDAQ: APHA ) doesn’t bode well for either stock. Source: Jarretera / Shut...

Previous 10 Next 10